Sabine Schmid - Concepedia

Author

Sabine Schmid

Kantonsspital St. Gallen ORCID

Also Known As

S Schmid, S. Schmid, S., Schmid, Sabine P. Schmid, Sabine Schmid, Schmid, S, Schmid, S.

123

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

Kantonsspital St. Gallen University of Bern University Hospital of Bern Swiss Group For Clinical Cancer Research University Hospital of Basel

About

Sabine Schmid is an author at Kantonsspital St. Gallen specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	16	1.5K
2	Immunology	2	2	1K
3	Engineering	1	1	13
4	Health Sciences	1	1	107
5	Cell Biology	1	1	68

Sabine Schmid

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab Stefan Diem, Sabine Schmid, M. Krapf, Lung Cancer MedicineImmunologyPathologyImmune Checkpoint InhibitorNeutrophil-to-lymphocyte Ratio	2017	992
The tumour-suppressive miR-29a/b1 cluster is regulated by CEBPA and blocked in human AML Marianne Eyholzer, Sabine Schmid, Ludwig Wilkens, British Journal of Cancer	2010	116
Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations Sabine Schmid, Aurelius Omlin, Celestia S. Higano, JAMA Network Open	2020	109
Organ-specific response to nivolumab in patients with non-small cell lung cancer (NSCLC) Sabine Schmid, Stefan Diem, Qiyu Li, Cancer Immunology Immunotherapy Organ-specific ResponseMedicineImmune Checkpoint InhibitorCancer TreatmentOncology	2018	107
Pembrolizumab as Palliative Immunotherapy in Malignant Pleural Mesothelioma Yannis Metaxas, Gareth Rivalland, Laetitia Mauti, Journal of Thoracic Oncology Malignant DiseaseRadiation OncologyPalliative ImmunotherapyPleural Disease	2018	91
C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer Niklas Klümper, Jonas Saal, Fiamma Berner, Journal for ImmunoTherapy of Cancer	2022	74
Clinical Outcome of ALK -Positive Non–Small Cell Lung Cancer (NSCLC) Patients with De Novo EGFR or KRAS Co-Mutations Receiving Tyrosine Kinase Inhibitors (TKIs) Sabine Schmid, Oliver Gautschi, Sacha I. Rothschild, Journal of Thoracic Oncology De Novo EgfrMedicinePathologyCancer TreatmentCancer Genetics	2016	72
Complexity of miR-223 regulation by CEBPA in human AML Marianne Eyholzer, Sabine Schmid, Julian Schardt, Leukemia Research Mir-223 RegulationSmall RnaGene ExpressionMedicineCell Biology	2009	68
Pilot Trial of Ondansetron in the Treatment of 8 Patients With Obsessive-Compulsive Disorder William A. Hewlett, Sabine Schmid, Ronald M. Salomon The Journal of Clinical Psychiatry	2003	65
Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung Cancer Miguel García-Pardo, Kasia Czarnecka‐Kujawa, Jennifer Law, JAMA Network Open	2023	57

Page 1